Dong-Wan Kim
Dong-Wan Kim
Seoul National University Hospital
Verified email at snu.ac.kr
Title
Cited by
Cited by
Year
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
RS Herbst, P Baas, DW Kim, E Felip, JL Pérez-Gracia, JY Han, J Molina, ...
The Lancet 387 (10027), 1540-1550, 2016
43522016
Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
AT Shaw, DW Kim, K Nakagawa, T Seto, L Crinó, MJ Ahn, T De Pas, ...
New England Journal of Medicine 368 (25), 2385-2394, 2013
33442013
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
BJ Solomon, T Mok, DW Kim, YL Wu, K Nakagawa, T Mekhail, E Felip, ...
N Engl j Med 371, 2167-2177, 2014
26052014
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...
Journal of Thoracic Oncology 11 (1), 39-51, 2016
18242016
AZD9291 in EGFR inhibitor–resistant non–small-cell lung cancer
PA Jänne, JCH Yang, DW Kim, D Planchard, Y Ohe, SS Ramalingam, ...
New England Journal of Medicine 372 (18), 1689-1699, 2015
17382015
Ceritinib in ALK-rearranged non–small-cell lung cancer
AT Shaw, DW Kim, R Mehra, DSW Tan, E Felip, LQM Chow, DR Camidge, ...
N Engl j med 370, 1189-1197, 2014
15492014
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
WTA Van Der Graaf, JY Blay, SP Chawla, DW Kim, B Bui-Nguyen, ...
The Lancet 379 (9829), 1879-1886, 2012
15162012
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
DAE Cross, SE Ashton, S Ghiorghiu, C Eberlein, CA Nebhan, PJ Spitzler, ...
Cancer discovery 4 (9), 1046-1061, 2014
14312014
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
DR Camidge, YJ Bang, EL Kwak, AJ Iafrate, M Varella-Garcia, SB Fox, ...
The lancet oncology 13 (10), 1011-1019, 2012
13332012
Elliptic Flow of Charged Particles in Pb-Pb Collisions at
K Aamodt, B Abelev, AA Quintana, D Adamova, AM Adare, MM Aggarwal, ...
Physical review letters 105 (25), 252302, 2010
12552010
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer
S Peters, DR Camidge, AT Shaw, S Gadgeel, JS Ahn, DW Kim, SHI Ou, ...
New England Journal of Medicine 377 (9), 829-838, 2017
12502017
Predictive and prognostic impact of epidermal growth factor receptor mutation in non–small-cell lung cancer patients treated with gefitinib
SW Han, TY Kim, PG Hwang, S Jeong, J Kim, IS Choi, DY Oh, JH Kim, ...
Journal of clinical oncology 23 (11), 2493-2501, 2005
9352005
Constraints on the spin-parity and anomalous couplings of the Higgs boson in proton collisions at 7 and 8 TeV
V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, T Bergauer, ...
Physical Review D 92 (1), 012004, 2015
8532015
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim, DW Kim, JY Chung, SG Shin, SC Kim, DS Heo, NK Kim, YJ Bang
Clinical cancer research 10 (11), 3708-3716, 2004
8112004
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled …
K Park, EH Tan, K O'Byrne, L Zhang, M Boyer, T Mok, V Hirsh, JCH Yang, ...
The Lancet Oncology 17 (5), 577-589, 2016
7612016
Scaling Properties of Azimuthal Anisotropy in and Collisions at
A Adare, S Afanasiev, C Aidala, NN Ajitanand, Y Akiba, H Al-Bataineh, ...
Physical review letters 98 (16), 162301, 2007
6152007
Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study
SHI Ou, JS Ahn, L De Petris, R Govindan, JCH Yang, B Hughes, H Lena, ...
Journal of clinical oncology 34 (7), 661-668, 2016
5762016
Enhanced Production of Direct Photons in Collisions at and Implications for the Initial Temperature
A Adare, S Afanasiev, C Aidala, NN Ajitanand, Y Akiba, H Al-Bataineh, ...
Physical review letters 104 (13), 132301, 2010
5492010
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee, KM Lee, DW Kim, DS Heo
The Journal of Immunology 172 (12), 7335-7340, 2004
5472004
The transcriptional landscape and mutational profile of lung adenocarcinoma
JS Seo, YS Ju, WC Lee, JY Shin, JK Lee, T Bleazard, J Lee, YJ Jung, ...
Genome research 22 (11), 2109-2119, 2012
5142012
The system can't perform the operation now. Try again later.
Articles 1–20